Cargando…
COVID-19: A Rare Cause of Hemolytic Uremic Syndrome
Hemolytic uremic syndrome (HUS) is a multisystemic condition characterized by a triad of acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. HUS can be classified as atypical or typical, depending upon its association with the Shiga toxin-producing Escherichia coli (STEC)....
Autores principales: | Boldig, Kimberly, Batra, Rishu, Villegas, Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466298/ https://www.ncbi.nlm.nih.gov/pubmed/36120203 http://dx.doi.org/10.7759/cureus.27962 |
Ejemplares similares
-
Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021) -
Hemophagocytic Lymphohistiocytosis and Clostridium difficile Infection: A Diagnostic Dilemma
por: Boldig, Kimberly, et al.
Publicado: (2023) -
A Case of COVID-19-Associated Autoimmune Hemolytic Anemia With Hyperferritinemia in an Immunocompetent Host
por: Huda, Zoha, et al.
Publicado: (2021) -
Ceftriaxone-Induced Immune Hemolytic Anemia
por: Singh, Anil, et al.
Publicado: (2020) -
Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)